READY or Not: Reliable Enterprise Agent Deployment
Veronica Chatrath, Bryan Zhu, Jingxuan Fan, George Pu, Soham Dinesh Tiwari, Soham Dan, Ryan Young, Yuan, et al.
cs.AI
Quick verdict
READY framework statistically qualifies human-AI agent deployment under oversight policies; conceptually strong, but validated on only one clinical workflow.
Summary
The paper argues that autonomous benchmark accuracy does not determine whether an AI agent can be deployed, and introduces READY (Reliable Enterprise Agent Deployment), a framework that casts deployment qualification as constrained optimization over a class of human-oversight policies. Given a workflow, an agent, and candidate policies, READY measures the reliability and operating cost of the human-AI system, selects the minimum-cost policy meeting a reliability target on development data, freezes it, and statistically qualifies the frozen policy on held-out cases via a one-sided confidence bound. It is implemented as an open testbed on Inspect AI. In a case study on CliniCARE-Bench retrospective clinical audit (16 agent systems, 750 cases, 12,000 runs), using self-reported confidence as the routing signal and an assumed 0.9 human-review success rate, two systems 0.3 percentage points apart in autonomous accuracy (72.8% vs 72.5%) need 39.2% vs 29.6% human review to qualify at a 76% reliability target. Routing quality (AUROC) is essentially uncorrelated with base accuracy (rho = -0.12). Main limitations: empirical evidence covers one workflow and terminal accept-or-escalate routing only; human review is assumed rather than measured; and qualification rests on a single fixed 375/375 split.
Review complete
Assessment at a glance
5
risk flags identified
● high 0
● medium 3
● low 2
5 strengths · 5 weaknesses · 5 author questions
AI text signal = Binoculars zero-shot detector score over 20 sampled passages (Fast-DetectGPT co-reported) — absence does not prove human authorship, and a flag does not imply misconduct.
Levels reflect verification complexity — not a quality score. Evolve never rates your paper.
Key claims under review
- Autonomous benchmark accuracy does not determine deployment value: two systems 0.3 percentage points apart in accuracy (72.8% vs 72.5%) require 39.2% vs 29.6% human review to qualify at the same 76% reliability target.
- Deployment qualification should be cast as constrained optimization over oversight policies, with policy selection on development data and statistical qualification of the frozen policy on held-out cases.
- Routing-signal quality (AUROC) is essentially uncorrelated with base accuracy (rho = -0.12), so capability leaderboards cannot predict the oversight cost of reliable deployment.
- Terminal accept-or-escalate policies can be qualified efficiently by replaying saved trajectories, producing conditional deployment claims that separate measured evidence from the assumed human-review success rate.
Strengths
Selection/qualification separation is a genuine methodological rigor upgrade
Policy selection on a development split with margin delta = 0.05 (Eq. 45), then frozen-threshold evaluation on 375 held-out cases with a one-sided 95% lower confidence bound (Eqs. 26-29, Appendix B.1). The margin is empirically justified: qualification rates across the 31-target sweep rise from 46% to 95% (Section 5.5) - a selection-bias effect most agent evaluations never control for.
Honest treatment of the unmeasured human-review path
All qualification claims are explicitly conditional on the assumed review success ah = 0.9; Clopper-Pearson confidence is attached only to the observed accepted component, none to the assumed term (Section 3.5, B.1 step 3). Per-system break-even amin_h (Table 3) makes the assumption's leverage auditable, and B.2 sweeps ah over {0.80-1.00}, exposing the structural 0.90 reliability ceiling.
Non-obvious empirical findings, including counterexamples to its own single-target metric
Failure modes are surfaced, not hidden
Deployment-grade provenance design
Weaknesses
Single-workflow empirical base
Routing signal never compared against alternatives
Human-review effectiveness assumed, not measured
One fixed 375/375 split, no resampling variance
Cost analysis collapses to review percentage in practice
Full Review Report
$1.99 · one-timeUnlock the complete preliminary analysis Evolve produced for this paper.
Report preview
Scope & Claims
READY (Sections 1-3) reframes agent evaluation from "how well does the agent perform autonomously?" to "under what oversight policy, and at what cost, can the human-AI system meet a required reliability level?" The formal objective (Eqs. 8-9) selects the minimum-cost oversight policy subject to R(pi) >= Y plus an optional risk constraint, then freezes the policy and statistically qualifies it on held-out cases. The paper claims a deployment-centered evaluation objective, a selection-plus-qualification method, and an open testbed built on Inspect AI (Sections 3-4). The headline empirical claim (Sections 5.5-5.6, Table 3): GPT-5.4 and Claude Sonnet 5, separated by 0.3 percentage points in four-way autonomous accuracy (72.8% vs 72.5%), require 39.2% vs 29.6% human review to qualify at reliability target Y = 0.76 under assumed review success ah = 0.90. Claims are consistently scoped as conditional, lineage-bound statements (Section 4.6) rather than intrinsic agent scores - a strength in itself.
The remaining sections cover Methodology Assessment, Statistical Evidence, Results & Reproducibility, Limitations & Risks, and Verdict & Recommendations.
- All 5 strengths & 5 weaknesses, analyzed in detail
- 5 risk flags with severity, section & reviewer questions
- Methods & statistical evidence assessment
- 5 questions a peer reviewer would ask
- Full six-dimension evaluation report & recommendations
One-time purchase · this paper only
One-time purchase, this paper only. AI-generated preliminary analysis — not peer review.
Frequently asked questions
What is the READY framework for AI agent deployment?
READY (Reliable Enterprise Agent Deployment), from Scale AI researchers, is an evaluation framework that decides whether an AI agent can be deployed on an enterprise workflow by optimizing a human-oversight policy to meet a reliability target at minimum operating cost, then statistically testing that frozen policy on held-out cases. Its output is a 'deployment profile': qualified policy, reliability with confidence bound, human-review burden, cost, and the assumptions the claim depends on.
What is the paper's key finding?
On a retrospective clinical-audit benchmark (CliniCARE-Bench), two agent systems with nearly identical autonomous accuracy (72.8% vs 72.5%) required very different human review rates (39.2% vs 29.6%) to reach the same 76% reliability target - because one system's self-reported confidence ranks its own errors much better than the other's. The lesson: benchmark leaderboards cannot predict how much human oversight a deployment will need.
What are the main limitations of the study?
Evidence comes from a single workflow and a simple accept-or-escalate policy; human review success is assumed at 0.9 rather than measured with real reviewers; qualification uses a single fixed 375/375 case split with no resampling variance; and the routing signal is only the models' self-reported confidence, with no comparison against stronger uncertainty signals the related-work section itself lists.
Is the code or data for this paper available?
The paper states READY is implemented as an open, extensible testbed built on the public Inspect AI framework, and evaluates the public CliniCARE-Bench dataset. A concrete repository URL is not shown in the provided excerpt; the paper's project page is listed as scale.com/research.
About this review
This is an AI-generated preliminary review by Evolve.Pub, produced from the openly available text of the paper. It is not peer review and does not represent the authors' views. The canonical record of the paper is at the publisher link above.
- Sampled excerpt with '[...sampling gap...]' skips: parts of Section 3.1, Sections 4.3-4.5, parts of Related Work (6.1-6.3) and chunks of the reference list are not visible; core assessments rest on the fully shown Sections 2-3, 5, 6.4-6.7, 7-8 and Appendix B.1-B.2.
- Appendix B is cut off mid-table in B.2 (per-system ah-sensitivity rows end at Sonnet 5); B.3-B.5, including the 'cost-of-conflation control' referenced in Section 5, are not present in the excerpt.
- Figures 1-3 appear only as caption and axis text in the extraction; the plotted curve data could not be independently verified.
Go deeper on this paper
Wrote a paper? Stress-test it before reviewers do.
Upload your manuscript for the same structured scrutiny — reasoning, statistics, evidence, figures, and reproducibility.